RFG Advisory’s iRadimed IRMD Stock Holding History

RFG Advisory’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,384	Closed	-$1.59M	–	1082
2025 Q4	$1.59M	Buy	+16,384	New	+$1.41M	0.03%	398

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RFG Advisory's IRMD Position: Q1 2026 in Review

RFG Advisory sold out of iRadimed (IRMD) in Q1 2026, closing a stake of 16,384 shares — an estimated $1.59M sold.

RFG Advisory first reported a position in IRMD in Q4 2025 and held it in 1 quarter. The position peaked at $1.59M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

RFG Advisory reported no remaining iRadimed position as of Q1 2026 after selling out during the quarter.
RFG Advisory sold 16,384 iRadimed shares in Q1 2026, an estimated $1.59M.
RFG Advisory first reported a position in iRadimed in Q4 2025 and held it in 1 quarter.
RFG Advisory's iRadimed position peaked at $1.59M in Q4 2025.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on RFG Advisory's 13F filing for Q1 2026, filed 20 Apr 2026.